Article

Insurers Forcing Patients to Pay More for Costly Specialty Drugs

prescription drugs

cancer

r

heumatoid arthritis

Thousands of patients in California and across the nation who take expensive every month for , and other ailments are facing sticker shock at the pharmacy.

Aetna

Until recently, most of these patients typically paid modest co-pays for the advanced drugs. But increasingly, Anthem Blue Cross, and other insurers are shifting more prescriptions to a new category requiring patients to shoulder a larger share of the drug's cost.

Read the full story: http://hcp.lv/KXEKBf

Source: Los Angeles Times

Related Videos
Screenshot of Adam Colborn, JD during an interview
Wanmei Ou, PhD, vice president of product, data analytics, and AI at Ontada
Glenn Balasky, executive director of the Rocky Mountain Cancer Center.
Corey McEwen, PharmD, MS
dr linda bosserman
dr andrew leitner
Glenn Balasky during a video interview
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo